Announcements Launching Strateos's San Diego Region We're excited to announce we're launching our newest region in San Diego, California.
Announcements Transcriptic and 3Scan Combine to Form Strateos The boards of Transcriptic and 3Scan have unanimously approved an agreement to merge companies to combine their considerable engineering capabilities in developing automated systems for chemistry, biology, and tissue analysis. The resulting new company is Strateos
Announcements 3Scan Awarded a Prestigious NIH Grant to Advance its Novel Automated Sectioning and Imaging Technology San Francisco, CA, Oct. 29, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan), the world’s leading 3D tissue imaging company has been awarded a Phase I Small Business Innovation Research
Announcements Announcing Our Exciting Collaboration with Eli Lilly in San Diego Transcriptic has entered into a multi-year collaboration agreement with Eli Lilly and Company to transform how new drugs are discovered. Menlo Park, CA – July 24, 2018 –Transcriptic announced today that
Announcements Transcriptic Expands Executive Team To Support Continued Growth Transcriptic, developer of the first robotic cloud laboratory platform, announced today the appointments of Christopher Krueger as Chief Financial Officer and Kevin Sturdevant as Vice President, Business Operations.
Announcements Transcriptic Appoints Dr Jeff Finer, M.D., Ph. D. to Board of Directors Life science veteran Dr. Finer is a Venture Partner with Third Rock Ventures and has 30 years research and clinical experience. Transcriptic, the first robotic cloud laboratory platform, today announced
Synthetic Biology Transcriptic and Ginkgo Bioworks Selected By DARPA To Accelerate Biological Design with $9.5M Award Synergistic Discovery and Design Program to facilitate creation of a cloud-based experimental design platform and open data exchange.
Synthetic Biology Announcing our collaboration with Ginkgo Bioworks To Accelerate Automation in Organism Design Five year, $10 million+ deal with robotic cloud lab will double Ginkgo’s foundry output; increase scale of its synthetic biology innovation
